BSV introduces Adverse Event Reporting Application: Pivotal stride in strengthening Patient’s safety
In a significant development, Bharat Serums and Vaccines Limited (BSV), one of India’s leading biopharmaceutical companies, has launched a new communication tool called ‘BSV AER’. This innovative mobile-based application aims to streamline the reporting of potential adverse events that may occur after the use of BSV products, thereby enhancing patient safety.
The Importance of Adverse Event Reporting
Adverse events refer to any untoward medical occurrence that happens after the use of a drug or vaccine. These events can range from mild side effects to severe complications. It is crucial for healthcare professionals (HCPs) and consumers to report such events so that the pharmaceutical industry and regulatory authorities can assess the safety profile of a drug and take necessary action if required.
The Features of BSV AER
BSV AER is a user-friendly mobile application that allows HCPs, consumers, and company personnel to report potential adverse events electronically from their smartphones or tablets. The application is directly connected to BSV’s pharmacovigilance system, ensuring seamless communication and prompt response.
Key Benefits of BSV AER
One of the main advantages of the BSV AER application is its simplicity and convenience. Users can
easily upload information about potential adverse events, enabling timely reporting without the risk of losing any crucial details. This, in turn, allows BSV’s medical and scientific personnel to evaluate the reported event and provide prompt feedback to HCPs and consumers, ensuring effective management of adverse events.Sanjiv Navangul, MD & CEO of BSV, emphasizes the importance of robust adverse event reporting tools in the evolving pharmaceutical industry. He believes that the BSV AER application will be a significant milestone in advancing pharmacovigilance practices in India. He also highlights the need to communicate with HCPs regarding both the beneficial and adverse events associated with BSV products.
Dr. Swashraya Shah, Chief Medical Officer of BSV, emphasizes the significance of careful analysis of adverse events reported by HCPs and consumers. This analysis helps the pharmaceutical industry and regulatory authorities assess the incidence and severity of adverse events. BSV thoroughly assesses every adverse event to enhance their knowledge of their medicines and share this information with HCPs for effective patient management.
The introduction of BSV AER marks a breakthrough in strengthening patient safety. This mobile-based application provides a powerful platform for reporting and managing potential adverse events related to BSV products. Its user-friendly interface and seamless integration with BSV’s pharmacovigilance system make it an invaluable tool for HCPs, consumers, and company personnel.
Keywords: adverse event reporting, patient safety, BSV AER, pharmacovigilance, healthcare professionals, mobile application, BSV products, pharmaceutical industry, regulatory authorities
